Artiva Biotherapeutics, Inc. (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

3.360

-0.415 (-10.99%)

At close: Dec 5, 2025, 4:00 PM EST

3.340

-0.020 (-0.60%)

After-hours: Dec 5, 2025, 7:40 PM EST

Artiva Biotherapeutics Employees

Artiva Biotherapeutics had 89 employees as of December 31, 2024. The number of employees increased by 46 or 106.98% compared to the previous year.

Employees

89

Change

46

Growth

106.98%

Revenue / Employee

n/a

Profits / Employee

-$889,753

Market Cap

82.47M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	89	46	106.98%
Dec 31, 2021	43	21	95.45%
Dec 31, 2020	22	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ARTV News

23 days ago - Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease - GlobeNewsWire
23 days ago - Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
4 weeks ago - Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK® - GlobeNewsWire
5 weeks ago - Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewsWire
7 weeks ago - Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update - GlobeNewsWire
3 months ago - Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025 - GlobeNewsWire
4 months ago - Artiva (ARTV) Q2 Loss Widens 19.7% - The Motley Fool
4 months ago - Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights - GlobeNewsWire